219 related articles for article (PubMed ID: 21225593)
1. Involvement of ADAMTS5 and hyaluronidase in aggrecan degradation and release from OSM-stimulated cartilage.
Durigova M; Troeberg L; Nagase H; Roughley PJ; Mort JS
Eur Cell Mater; 2011 Jan; 21():31-45. PubMed ID: 21225593
[TBL] [Abstract][Full Text] [Related]
2. Characterization of an ADAMTS-5-mediated cleavage site in aggrecan in OSM-stimulated bovine cartilage.
Durigova M; Soucy P; Fushimi K; Nagase H; Mort JS; Roughley PJ
Osteoarthritis Cartilage; 2008 Oct; 16(10):1245-52. PubMed ID: 18372197
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of proteoglycan aggregate degradation in cartilage stimulated with oncostatin M.
Durigova M; Roughley PJ; Mort JS
Osteoarthritis Cartilage; 2008 Jan; 16(1):98-104. PubMed ID: 17574450
[TBL] [Abstract][Full Text] [Related]
4. MMPs are less efficient than ADAMTS5 in cleaving aggrecan core protein.
Durigova M; Nagase H; Mort JS; Roughley PJ
Matrix Biol; 2011 Mar; 30(2):145-53. PubMed ID: 21055468
[TBL] [Abstract][Full Text] [Related]
5. The effect of protease inhibitors on the induction of osteoarthritis-related biomarkers in bovine full-depth cartilage explants.
He Y; Zheng Q; Jiang M; Sun S; Christiansen TG; Kassem M; Karsdal MA; Bay-Jensen AC
PLoS One; 2015; 10(4):e0122700. PubMed ID: 25909781
[TBL] [Abstract][Full Text] [Related]
6. The cleavage of biglycan by aggrecanases.
Melching LI; Fisher WD; Lee ER; Mort JS; Roughley PJ
Osteoarthritis Cartilage; 2006 Nov; 14(11):1147-54. PubMed ID: 16806997
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide enhances aggrecan degradation by aggrecanase in response to TNF-alpha but not IL-1beta treatment at a post-transcriptional level in bovine cartilage explants.
Stevens AL; Wheeler CA; Tannenbaum SR; Grodzinsky AJ
Osteoarthritis Cartilage; 2008 Apr; 16(4):489-97. PubMed ID: 17923423
[TBL] [Abstract][Full Text] [Related]
8. Effects of glucocorticoids and interleukin-1 beta on expression and activity of aggrecanases in equine chondrocytes.
Busschers E; Holt JP; Richardson DW
Am J Vet Res; 2010 Feb; 71(2):176-85. PubMed ID: 20113225
[TBL] [Abstract][Full Text] [Related]
9. Aggrecanolysis in human osteoarthritis: confocal localization and biochemical characterization of ADAMTS5-hyaluronan complexes in articular cartilages.
Plaas A; Osborn B; Yoshihara Y; Bai Y; Bloom T; Nelson F; Mikecz K; Sandy JD
Osteoarthritis Cartilage; 2007 Jul; 15(7):719-34. PubMed ID: 17360199
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase R plays a pivotal role in oncostatin M and interleukin-1 signalling in bovine articular cartilage chondrocytes.
Gilbert SJ; Blain EJ; Al-Sabah A; Zhang Y; Duance VC; Mason DJ
Eur Cell Mater; 2012 Jan; 23():41-57. PubMed ID: 22287113
[TBL] [Abstract][Full Text] [Related]
11. Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage.
Patwari P; Gao G; Lee JH; Grodzinsky AJ; Sandy JD
Osteoarthritis Cartilage; 2005 Apr; 13(4):269-77. PubMed ID: 15780640
[TBL] [Abstract][Full Text] [Related]
12. MMP proteolysis of the human extracellular matrix protein aggrecan is mainly a process of normal turnover.
Struglics A; Hansson M
Biochem J; 2012 Sep; 446(2):213-23. PubMed ID: 22670872
[TBL] [Abstract][Full Text] [Related]
13. Aggrecanase and aggrecan degradation in osteoarthritis: a review.
Huang K; Wu LD
J Int Med Res; 2008; 36(6):1149-60. PubMed ID: 19094423
[TBL] [Abstract][Full Text] [Related]
14. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation.
Tortorella MD; Malfait AM; Deccico C; Arner E
Osteoarthritis Cartilage; 2001 Aug; 9(6):539-52. PubMed ID: 11520168
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1alpha treatment of meniscal explants stimulates the production and release of aggrecanase-generated, GAG-substituted aggrecan products and also the release of pre-formed, aggrecanase-generated G1 and m-calpain-generated G1-G2.
Lemke AK; Sandy JD; Voigt H; Dreier R; Lee JH; Grodzinsky AJ; Mentlein R; Fay J; Schünke M; Kurz B
Cell Tissue Res; 2010 Apr; 340(1):179-88. PubMed ID: 20217136
[TBL] [Abstract][Full Text] [Related]
16. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5.
Song RH; Tortorella MD; Malfait AM; Alston JT; Yang Z; Arner EC; Griggs DW
Arthritis Rheum; 2007 Feb; 56(2):575-85. PubMed ID: 17265492
[TBL] [Abstract][Full Text] [Related]
17. Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2).
Chockalingam PS; Zeng W; Morris EA; Flannery CR
Arthritis Rheum; 2004 Sep; 50(9):2839-48. PubMed ID: 15457452
[TBL] [Abstract][Full Text] [Related]
18. Glycosaminoglycan-binding properties and aggrecanase activities of truncated ADAMTSs: comparative analyses with ADAMTS-5, -9, -16 and -18.
Zeng W; Corcoran C; Collins-Racie LA; Lavallie ER; Morris EA; Flannery CR
Biochim Biophys Acta; 2006 Mar; 1760(3):517-24. PubMed ID: 16507336
[TBL] [Abstract][Full Text] [Related]
19. TNF-α and IL-1β promote a disintegrin-like and metalloprotease with thrombospondin type I motif-5-mediated aggrecan degradation through syndecan-4 in intervertebral disc.
Wang J; Markova D; Anderson DG; Zheng Z; Shapiro IM; Risbud MV
J Biol Chem; 2011 Nov; 286(46):39738-49. PubMed ID: 21949132
[TBL] [Abstract][Full Text] [Related]
20. The nutraceutical flavonoid luteolin inhibits ADAMTS-4 and ADAMTS-5 aggrecanase activities.
Moncada-Pazos A; Obaya AJ; Viloria CG; López-Otín C; Cal S
J Mol Med (Berl); 2011 Jun; 89(6):611-9. PubMed ID: 21365186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]